Association between the body mass index and chronic kidney disease in men and women. A population-based study from Israel

Nephrology Dialysis Transplantation

Volumn 28, Issue SUPPL.4, 2013, Pages

  Cohen, Eytan ^a,c   Fraser, Abigail ^b   Goldberg, Elad ^a,c   Milo, Gai ^a,c   Garty, Moshe ^a,c   Krause, Ilan ^a,c  

^a RABIN MEDICAL CENTER   (Israel)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Body mass index; Chronic kidney disease; CKD EPI equation; Gender

Indexed keywords

ADULT; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBID OBESITY; OBESITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT;

BODY MASS INDEX; CHRONIC KIDNEY DISEASE; CKD-EPI EQUATION; GENDER;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; ISRAEL; MALE; MIDDLE AGED; OBESITY, MORBID; ODDS RATIO; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; SEX FACTORS; YOUNG ADULT;

EID: 84890031398     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft072     Document Type: Article

References (27)

1. James PT, Leach R, Kalamara E et al. The worldwide obesity epidemic. Obes Res 2001; 9: 228S-233S
2. Hallan S, de Mutsert R, Carlsen S et al. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis 2006; 47: 396-405
3. Nomura I, Kato J, Kitamura K. Association between body mass index and chronic kidney disease: a population-based, crosssectional study of a Japanese Community. Vasc Health Risk Manag 2009; 5: 315-320
4. Shankar A, Leng C, Chia KS et al. Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore. Nephrol Dial Transplant 2008; 23: 1910-1918
5. Ejerblad E, Fored CM, Lindblad P et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702
6. Kramer H, Luke A, Bidani A et al. Obesity and prevalent and incident CKD: the hypertension detection and follow-up program. Am J Kidney Dis 2005; 46: 587-594
7. Hsu CY, McCulloch CE, Iribarren C et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28
8. Gelber RP, Kurth T, Kausz AT et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005; 46: 871-880
9. Iseki K, Ikemiya Y, Kinjo K et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876
10. Stengel B, Tarver-Carr ME, Powe NR et al. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003; 14: 479-487
11. Mohsen A, Brown R, Hoefield R et al. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus. J Nephrol 2012; 25: 384-393
12. Brown RN, Mohsen A, Green D et al. Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects. Nephrol Dial Transplant 2012; 27: 2776-2780
13. Khedr A, Khedr E, House AA. Body mass index and the risk of progression of chronic kidney disease. J Ren Nutr 2011; 21: 455-461
14. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278-285
15. Rowe JW, Andres R, Tobin JD et al. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 1976; 31: 155-163
16. Levey AS, Coresh J, Balk E et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147
17. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
18. Michels WM, Grootendorst DC, Verduijn M et al. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 2010; 5: 1003-1009
19. Ritz E, Koleganova N. Obesity and chronic kidney disease. Semin Nephrol 2009; 29: 504-511
20. Weisinger JR, Kempson RL, Eldridge FL et al. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974; 81: 440-447
21. Chen HM, Liu ZH, Zeng CH et al. Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis 2006; 48: 772-779
22. Eckel RH, Alberti KG, Grundy SM et al. The metabolic syndrome. Lancet 2010; 375: 181-183
23. Sarafidis PA, Whaley-Connell A, Sowers JR et al. Cardiometabolic syndrome and chronic kidney disease: what is the link? J Cardiometab Syndr 2006; 1: 58-65
24. Cassis LA, Police SB, Yiannikouris F et al. Local adipose tissue renin-angiotensin system. Curr Hypertens Rep 2008; 10: 93-98
25. Vogt B, Bochud M, Burnier M. The association of aldosterone with obesity-related hypertension and the metabolic syndrome. Semin Nephrol 2007; 27: 529-537
26. Sharma K, Ramachandrarao S, Qiu G et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 2008; 118: 1645-1656
27. Sanchez-Lozada LG, Tapia E, Jimenez A et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 2007; 292: F423-429